foxo4 dri senolytic human trial Buy FOXO4-DRI 10mg | Third-Party Tested The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI 5mg 99 EU COA, fast EU shipping PeptidLabs FOXO4 DRI 10mg vial Description RCpeptides FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4 DRI Vial 10mg Stemcode Peptides
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




